Point-of-care testing, near-patient testing and patient self-testing: warning points.
ethics
near-patient testing
patient self-testing
point of care testing
quality
safety
Journal
Clinical chemistry and laboratory medicine
ISSN: 1437-4331
Titre abrégé: Clin Chem Lab Med
Pays: Germany
ID NLM: 9806306
Informations de publication
Date de publication:
08 May 2024
08 May 2024
Historique:
received:
26
04
2024
accepted:
28
04
2024
medline:
7
5
2024
pubmed:
7
5
2024
entrez:
7
5
2024
Statut:
aheadofprint
Résumé
Point-of-care testing (POCT), near-patient testing (NPT) and patient self-tests (PST) are diagnostic examinations performed at the time and place of patient care. While POCT and NPT are performed and analyzed by medical professionals, PST are based on samples and parameters directly collected and analyzed by lay users. These tests are spreading both in high income countries and in low to middle income countries as they are expected to improve healthcare efficiency and equity, by saving resources, releasing pressure from hospitals and reducing logistical barriers. However, accurate multidisciplinary assessment is mandatory to ensure that what they promise is real. We reviewed some important ethical aspects, international standards and regulations. The current risks associated with alternative ways of testing are explained by the principles of respect for patient autonomy and non-maleficence. Further evidence from multidisciplinary assessment is needed to evaluate pros and cons in light of the principles of beneficence and justice. Although POCT or NPT need common regulation and accurate provider training to ensure safe and appropriate interpretation of results, PST needs even more attention as they are subject to direct patient use. Randomized controlled trails including patient education should be conducted in order to provide reliable evidence on clinical outcomes, patient acceptance and cost-effectiveness. Mandatory regulation is needed to avoid harm and EU regulation should help different countries maintain a safe use of devices in a global population of producers and users.
Identifiants
pubmed: 38711414
pii: cclm-2024-0525
doi: 10.1515/cclm-2024-0525
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 Walter de Gruyter GmbH, Berlin/Boston.
Références
Gardiner, C, Williams, K, Mackie, IJ, Machin, SJ, Cohen, H. Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring. Br J Haematol 2005;128:242–7. https://doi.org/10.1111/j.1365-2141.2004.05300.x .
doi: 10.1111/j.1365-2141.2004.05300.x
Ansell, J, Jacobson, A, Levy, J, Völler, H, Hasenkam, JM, International Self-Monitoring Association for Oral Anticoagulation . Guidelines for implementation of patient self-testing and patient self-management of oral anticoagulation. International consensus guidelines prepared by international self-monitoring association for oral anticoagulation. Int J Cardiol 2005;99:37–45. https://doi.org/10.1016/j.ijcard.2003.11.008 .
doi: 10.1016/j.ijcard.2003.11.008
Food and Drug Administration , 2023. FDA authorizes first over-the-counter at-home test to detect both influenza and COVID-19 viruses | FDA. [Accessed 25 Mar 2024].
Jean, S, Burnham, CD, Chapin, K, Garner, OB, Pant Pai, N, Turabelidze, G, et al.. At-home testing for infectious diseases: the laboratory where you live. Clin Chem 2021;68:19–26. https://doi.org/10.1093/clinchem/hvab198 .
doi: 10.1093/clinchem/hvab198
Karon, BS. At-home molecular diagnostics: just around the corner or years away? J Appl Lab Med 2024;9:168–71. https://doi.org/10.1093/jalm/jfad070 .
doi: 10.1093/jalm/jfad070
Beauchamp, TL, Childress, JF. Principles of biomedical ethics , 7th ed. Oxford: Oxford University Press; 2013:480 p.
Bain, LE, Ditah, CM, Awah, PK, Ekukwe, NC. Ethical implications of HIV self-testing: the game is far from being over. Pan Afr Med J 2016;25:114. https://doi.org/10.11604/pamj.2016.25.114.8303 .
doi: 10.11604/pamj.2016.25.114.8303
Joshi, K, Harris, M, Cotterill, A, Wentworth, JM, Couper, JJ, Haynes, A, et al.. Continuous glucose monitoring has an increasing role in pre-symptomatic type 1 diabetes: advantages, limitations, and comparisons with laboratory-based testing. Clin Chem Lab Med 2023;62:41–9. https://doi.org/10.1515/cclm-2023-0234 .
doi: 10.1515/cclm-2023-0234
O’Kane, MJ. Patient self-testing in chronic disease management. J Lab Med 2020;44:81–7. https://doi.org/10.1515/labmed-2019-0175 .
doi: 10.1515/labmed-2019-0175
Franchin, T, Faggiano, F, Plebani, M, Muraca, M, De Vivo, L, Derrico, P, et al.. Adopting European network for health technology assessments (EunetHTA) core model for diagnostic technologies for improving the accuracy and appropriateness of blood gas analyzers’ assessment. Clin Chem Lab Med 2014;52:1569–77. https://doi.org/10.1515/cclm-2014-0087 .
doi: 10.1515/cclm-2014-0087
Clerico, A, Zaninotto, M, Plebani, M. High-sensitivity assay for cardiac troponins with POCT methods. The future is soon. Clin Chem Lab Med 2021;59:1477–8. https://doi.org/10.1515/cclm-2021-0620 .
doi: 10.1515/cclm-2021-0620
Wiencek, JR, Colby, JM, Nichols, JH. Rapid assessment of drugs of abuse. Adv Clin Chem 2017;80:193–225. https://doi.org/10.1016/bs.acc.2016.11.003 .
doi: 10.1016/bs.acc.2016.11.003
Poole, S, Townsend, J, Wertheim, H, Kidd, SP, Welte, T, Schuetz, P, et al.. How are rapid diagnostic tests for infectious diseases used in clinical practice: a global survey by the international society of antimicrobial chemotherapy (ISAC). Eur J Clin Microbiol Infect Dis 2021;40:429–34. https://doi.org/10.1007/s10096-020-04031-2 .
doi: 10.1007/s10096-020-04031-2
Doeppner, TR, Olbricht, L, Maxhuni, T, Alhaj Omar, O, Sachs, UJ, Juenemann, MB, et al.. Urine-based point-of-care testing for factor-Xa-inhibitors in acute ischemic stroke patients: a feasibility study. Front Neurol 2023;14:1330421. https://doi.org/10.3389/fneur.2023.1330421 .
doi: 10.3389/fneur.2023.1330421
Orth, M, Vollebregt, E, Trenti, T, Shih, P, Tollanes, M, Sandberg, S. Direct-to-consumer laboratory testing (DTCT): challenges and implications for specialists in laboratory medicine. Clin Chem Lab Med 2022;61:696–702. https://doi.org/10.1515/cclm-2022-1227 .
doi: 10.1515/cclm-2022-1227
Kalokairinou, L, Choi, R, Wei, NY, Wexler, A. Policies of US companies offering direct-to-consumer laboratory tests. JAMA Intern Med 2023;183:1275–8. https://doi.org/10.1001/jamainternmed.2023.4726 .
doi: 10.1001/jamainternmed.2023.4726
Pennestrì, F, Tomaiuolo, R, Banfi, G, Dolci, A. Blood over-testing: impact, ethical issues and mitigating actions. Clin Chem Lab Med 2024. https://doi.org/10.1515/cclm-2023-1227 [Epub ahead of print].
doi: 10.1515/cclm-2023-1227
Pennestrì, F, Banfi, G. Artificial intelligence in laboratory medicine: fundamental ethical issues and normative key-points. Clin Chem Lab Med 2022;60:1867–74. https://doi.org/10.1515/cclm-2022-0096 .
doi: 10.1515/cclm-2022-0096
Erasmus, R, Sahni, S, El-Sharkawy, R. Connectivity strategies in managing a POCT service. EJIFCC 2021;32:190–4.
De Vos, L, Daniel, J, Gebengu, A, Mazzola, A, Gleeson, B, Blumel, B, et al.. Implementation considerations for a point-of-care Neisseria gonorrhoeae rapid diagnostic test at primary healthcare level in South Africa: a qualitative study. BMC Health Serv Res 2024;24:43. https://doi.org/10.1186/s12913-023-10478-8 .
doi: 10.1186/s12913-023-10478-8
Howard, M. A market for diagnostic devices for extreme point-of-care testing: are we ASSURED of an ethical outcome? Develop World Bioeth 2024;24:84–96. https://doi.org/10.1111/dewb.12389 [Epub ahead of print].
doi: 10.1111/dewb.12389
Fitzmaurice, DA, Gardiner, C, Kitchen, S, Mackie, I, Murray, ET, Machin, SJ. An evidence-based review and guidelines for patient self-testing and management of oral anticoagulation [published correction appears in Br J Haematol. 2006 Jan;132(1):118]. Br J Haematol 2005;131:156–65. https://doi.org/10.1111/j.1365-2141.2005.05739.x .
doi: 10.1111/j.1365-2141.2005.05739.x
Oehme, R, Sandholzer-Yilmaz, AS, Heise, M, Frese, T, Fankhaenel, T. Utilization of point-of-care tests among general practitioners, a cross-sectional study. BMC Prim Care 2022;23:41. https://doi.org/10.1186/s12875-022-01643-9 .
doi: 10.1186/s12875-022-01643-9
Pecoraro, V, Germagnoli, L, Banfi, G. Point-of-care testing: where is the evidence? A systematic survey. Clin Chem Lab Med 2014;52:313–24. https://doi.org/10.1515/cclm-2013-0386 .
doi: 10.1515/cclm-2013-0386
European Confederation of Laboratory Medicine . European urinalysis guidelines. Scand J Clin Lab Invest Suppl 2000;231:1–86.
ISO 22870:2016 – Point-of-care testing (POCT) – Requirements for quality and competence.
ISO 15189:2022 – Medical laboratories – Requirements for quality and competence .
ISO/TS 22583 :2019 – Guidance for supervisors and operators of point-of-care testing (POCT) devices.
Official Journal of the European Union . Regulation (EU) 2017/746 of the European parliament and of the council of 5 April 2017 or in vitro diagnostic medical devices and repealing directive 98/79/EC and commission decision 2010/227/EU. Available from: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32017R0746 .